FDA authorizes Ito Invivyd’s pemivibart (Pemgarda), insights on Sofosbuvir levels in pregnant women, the effectiveness of fidaxomicin vs vancomycin for CDI treatment, and more this week from Contagion.
Shortened Treatment Regimen Resolves C difficile Infection
C difficile, Antimicrobials, and the Patients Most Affected
Investigational Antibiotic Comparable to Vancomycin in Curing C diff
Enhancing Clostridium difficile Treatment and Prevention Efforts
C diff Update: The Latest in Research, Clinical Management, and Patient Advocacy
Tracking the Evolution of Clostridioides difficile and Implications for Healthcare